The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.

Boasted as being a “breakthrough capsule formula designed to boost GLP-1 hormone levels, reduce hunger and cravings and ...

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish ...

Dietary supplements are designed to take the place of your usual meals. Packed with essentials like protein, fibre, vitamins, ...

“I am gobsmacked that Lilly is seeking confidential patient medical records to build a case against the very therapies that ...

Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...